Table III.
Hospital outcomes according to groups
| Variable | Conservative (n = 51) | Stenting (n = 9) | Surgery (n = 8) | P-value | |
|---|---|---|---|---|---|
| Laboratory characteristics | Baseline hematocrit (%) | 37.6 ±3.9 | 37.6 ±5.5 | 38.6 ±7.5 | 0.852 |
| Baseline platelet count [G/l] | 244.8 ±71 | 207.8 ±49.3 | 238.5 ±116.8 | 0.341 | |
| +Baseline creatinine [mg/dl] | 0.83 ±0.22 | 1.01 ±0.26 | 0.92 ±0.20 | 0.117 | |
| Nadir hematocrit (%) | 23.4 ±4.6 | 21.3 ±3.8 | 20.9 ±5.8 | 0.250 | |
| Nadir platelet count [G/l] | 141.9 ±82.2 | 105.3 ±56.3 | 104.2 ±80.5 | 0.202 | |
| Mean hematocrit drop (%) | 14.07 ±5.2 | 16.3 ±4.5 | 17.6 ±10.3 | 0.506 | |
| +Highest creatinine [mg/dl] | 1.56 ±1.31 | 1.46 ±0.46 | 3.1 ±1.55 | 0.013* | |
| Leukocytes at diagnosis | 18780 ±32356 | 17500 ±8035 | 20150 ±9342 | 0.982 | |
| Maximum size detected in abdominal CT [mm] | 142 ±59 | 138 ±42.8 | 189.7 ±83.5 | 0.326 | |
| Number of RBCP transfused [U] | 5 ±5.7 | 5.7 ±4.1 | 10.1 ±8.06 | 0.043* | |
| Time from procedure to CT, first 24 h | 19 (37.3%) | 1 (11.1%) | 1 (12.5%) | 0.143 | |
| Length of stay in hospital, mean ± SD [days] | 18 ±13 | 14 ±8 | 51 ±47 | 0.007* | |
| Mortality | 7 (13.7%) | 2 (22.2%) | 5 (62.5%) | 0.006* | |
CT – computed tomography, RBCP – red blood cell packs, + Patients with CRF were not included in the creatinine-related evaluation.
*
Differences between the groups statistically significant p < 0.05.